Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × Octreotide × Clear all

NCT01469338 2014-11-24

Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel

Phase 2 Terminated

Diarrhea, Prostatic Neoplasms

NCT00510224 2013-12-11

Sandostatin for Patients With Androgen Independent Prostate Cancer

Phase 2 Terminated

13 enrolled 4 charts

Prostatic Neoplasms